First malaria treatment for infants aged 2 months to 5 years approved by Swissmedic in July 2025. The breakthrough addresses a critical gap in pediatric malaria care across Africa.
← News
Disease Elimination Disease Elimination Health
Ending malaria in Africa: 5 essential reads on gains and challenges

2 Months To 5 Years Patient age range
Swissmedic Regulatory approval agency
July 2025 Approval date
2025 approval year